Discover life science companies across the East of England, including biotechnology firms, CROs, research organisations and innovation hubs.
Mixed-use science and technology park near Cambridge
Vision Park is a science, technology and finance business park located in Histon, approximately three miles north of Cambridge city centre. The park hosts a diverse range of tenants across life sciences, technology and professional services, with life science occupants including pharmaceutical, genomics, biotech…
Cambridge campus uniting biomedical research, hospitals and life sciences
Cambridge Biomedical Campus is a life sciences and healthcare campus bringing together hospitals, research institutes, universities and biotechnology companies. The site integrates clinical care, academic research and pharmaceutical development, enabling collaboration across drug discovery, translational medicine and…
Large-scale genomics research institute advancing human and pathogen biology
The Wellcome Sanger Institute is a genomics research institute on the Wellcome Genome Campus in Hinxton, funded by Wellcome. It made the largest single contribution to the Human Genome Project and has since expanded across cancer genomics, cellular genetics, infectious disease and parasitology. Research programmes…
Cyanobacterial synthetic biology platform producing sustainable specialty chemicals
Deep Blue Biotech is a biotechnology company using genetically engineered cyanobacteria to produce high-value specialty chemicals as sustainable alternatives to fossil-derived ingredients. The platform uses carbon dioxide, light, and water as primary inputs, guided by AI-driven metabolic modelling, to manufacture…
Research community connecting organoid and organ-on-a-chip scientists
WORC.Community is a research network connecting scientists working with organoids, organ-on-a-chip technologies and other new approach methodologies. Its online platform brings together scientific publications, research protocols, community discussions, networking opportunities and relevant events. WORC.Community also…
Regulatory affairs, pharmacovigilance and compliance services for life sciences
ProductLife Group is a life sciences consulting and outsourcing company providing regulatory affairs, pharmacovigilance and quality services to pharmaceutical, biotechnology and medical technology organisations. Its teams prepare regulatory submissions, manage product registrations, monitor medicine safety and support…
2D barcoded sample storage tubes and automated handling equipment
AltemisLab is a Cambridge-based manufacturer of 2D barcoded sample storage tubes, barcode readers, and automated capping and decapping equipment for laboratory sample management. Its range covers multiple storage formats including 96 SBS racks designed for short and long-term cryogenic storage. Complementary hardware…
Small molecule therapeutics targeting astrocytes in Parkinson's disease
Cellestial Health is a pre-clinical stage biotechnology company and University of Cambridge spinout developing small molecule therapeutics for Parkinson's disease and other neurodegenerative conditions. The company's approach targets astrocytic networks, a class of brain cells whose dysregulation contributes to…
Contract genomics services including Sanger and next-generation sequencing
GENEWIZ is a genomics services company and providing Sanger sequencing, next-generation sequencing, gene synthesis, oligo synthesis and bioinformatics services to pharmaceutical, biotechnology and academic customers worldwide. Its services span whole genome sequencing, RNA-seq, single-cell sequencing, metagenomics and…
Plasmonic PCR diagnostics for rapid infectious disease detection
RapidX Bio is a biotechnology company developing point-of-care molecular diagnostics for infectious diseases. Its plasmonic PCR technology uses light-responsive gold nanorods to accelerate nucleic acid amplification and reduce sample preparation requirements. The company is developing portable tests to identify…
Cambridge R&D hub for GPCR-based drug discovery
Nxera Pharma UK is the Cambridge-based drug discovery arm of Tokyo-listed Nxera Pharma, formerly Sosei Heptares, operating from Granta Park with approximately 170 scientists. Its structure-based drug discovery capabilities have produced over 50 resolved GPCR structures. Following a restructuring in November 2025, the…
Algal biotechnology company developing Chlorella-based food ingredients
Algenuity Limited is an algal biotechnology company that develops and supplies Chlorella-based ingredients for food and beverage manufacturers. Using proprietary strain engineering and heterotrophic fermentation, the company produces white Chlorella, a neutral-coloured, allergen-free, protein-rich ingredient suitable…
Biomimetic cell culture platform for reproducible cell therapy development
Stembond Technologies is a Cambridge University spin-out developing a synthetic, mechanically tuned biomimetic substrate that replicates the physical properties of human tissue microenvironments. The platform delivers reproducible cell culture conditions, reducing phenotypic drift and improving consistency across…
Alternative protein research, education and academic collaboration network
Cambridge University Alt Protein Project is a student-led ecosystem organisation connecting researchers, students and entrepreneurs working on alternative proteins. It supports education and collaboration across cultivated meat, plant-based foods and fermentation through workshops, academic mapping and scientific…
Longer-lasting RNA medicines and immune-stealthed CAR-T research
Cambridge RNA Technologies develops experimental RNA platforms intended to extend the duration of therapeutic gene expression. Its research includes technologies for longer-lasting RNA medicines. In collaboration with Anglia Ruskin University, the company has investigated immune-stealth approaches for donor-derived…
Fragment-based drug discovery platform for oncology and CNS disorders
Astex Pharmaceuticals is a drug discovery and development company pioneering fragment-based drug discovery through its proprietary Pyramid platform, applied to oncology and central nervous system disorders. Astex maintains an internal pipeline alongside active collaborations with MSD targeting KRAS and p53. The…
Birthplace of molecular biology researching fundamental processes in human disease
The MRC Laboratory of Molecular Biology researches fundamental biological processes at the level of atoms, molecules, cells and organisms, applying this knowledge to major problems in human health and disease. The Laboratory pioneered techniques including DNA sequencing, protein structure determination and the…
CRISPR-engineered tumour-infiltrating lymphocyte therapy
Intima Bioscience is a clinical-stage biotechnology company developing CRISPR gene-edited tumour-infiltrating lymphocyte therapies for solid tumours. Its platform targets CISH, an intracellular immune checkpoint that suppresses T cell activity against tumours; CRISPR knockout of CISH in patient-derived TILs enhances…
Fragment-based drug discovery with a glioblastoma focus
IOTA Pharmaceuticals is a Cambridge drug discovery company specialising in fragment-based design, molecular screening and computational approaches to early-stage therapeutics. Its research combines transcriptomics, phenotypic assays and natural product screening to investigate candidate treatments. A major focus is…
AI-guided RNA therapies for chronic metabolic diseases
Elarna Bio is a biotechnology company developing long-acting RNA therapeutics for chronic metabolic diseases. It combines AI-driven discovery with RNA engineering to improve the duration of therapeutic activity. The platform focuses on challenges associated with liver-targeted RNA treatments and is intended for…